This article was originally published in The Gray Sheet
Cigna is the latest major payer to cover Johnson & Johnson/DePuy Spine's Charité artificial lumbar disc, the firm announces July 25. Cigna, which provides health insurance to 47 million people, joins Kaiser Permanente and Aetna, among others, who cover use of the device to treat degenerative disc disease. CMS and other payers' hesitance to cover the device, particularly due to lack of long-term follow-up data, has slowed acceptance of the procedure in the United States (1"The Gray Sheet" June 4, 2007, p. 5). DePuy says five-year Charité data is expected to be published this year...
You may also be interested in...
CMS is proposing to extend its national non-coverage policy for Johnson & Johnson/DePuy's Charité to all current and future artificial lumbar discs
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.